b. Arrayit reports $155,000 microarray platform RFQ from the United States Food and Drug Administration FDA c. 1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov d. 3-14-18: Arrayit clinical team submits requested standard operating procedures SOPs and other documentation required for submission of a major microarray technology product to the United States Food and Drug Administration FDA for FDA regulatory clearance https://www.fda.gov e. 4-30-18: Arrayit government contracts team quotes $76,500 microarray life sciences instrument sale to a top official at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland and ensuring the safety of the nation's food and drugs https://www.fda.gov f. 5-17-18: Arrayit clinical team confirms meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major product line. The FDA is headquartered in Silver Spring Maryland USA and improves healthcare by ensuring public safety https://www.fda.gov g. 6-19-18: Arrayit CLIA clinical team confirms July 2 2018 meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major microarray product line. The FDA is HQ in Maryland USA and funded by a massive $4.9 billion annual budget https://www.fda.gov